Oculus and BHVI (Brien Holden Vision Institute) have announced an agreement that will allow Oculus to incorporate BHVI’s algorithms for tracking and estimating refractive error into its Myopia Master ophthalmic instruments developed for the management of myopia.
The Oculus Myopia Master combines important measurements for myopia management: axial length, refraction values and the central corneal radii. Axial length measurement is regarded by many experts as the gold standard for myopia management. This quick, contactless and extremely accurate measurement method is not influenced by the accommodation status of the eye and delivers reproducible results also in children.
“This license agreement is another example of the cutting edge technologies that BHVI is engaged in. BHVI literally ‘wrote the book’ on myopia when its seminal research paper Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050 was published in 2016. Our agreement with Oculus will see our research translated into more instruments that optometrists can use to manage myopia, globally,” Yvette Waddell, BHVI’s CEO, said in a company news release.
“Through working with and incorporating BHVI’s unique technology into our Myopia Master, we can continue to deliver world class instruments to our clients,” Christian Kirchhübel, CEO of Oculus, said in the news release. “We are delighted that the Myopia Master device will make some of the knowledge generated by BHVI with expansive datasets accessible to eye specialists around the world.”
Myopia (often called nearsightedness) makes seeing distant objects difficult and causes the eyeball to change shape. According to BHVI, currently around 30 % of the world is myopic. Research conducted at BHVI predicts that by 2050, almost 50 % of the world’s population will be myopic.
The Oculus Myopia Master is not for sale yet.